Evidence map›Paper›PMID 31315826›Full record

ArticleBritish journal of sports medicine2020

The Italian preparticipation evaluation programme: diagnostic yield, rate of disqualification and cost analysis.

Teresina Vessella, Alessandro Zorzi, Laura Merlo, Cinzia Pegoraro, Flaviano Giorgiano, Michele Trevisanato, Mirella Viel, Pietro Formentini, Domenico Corrado, Patrizio Sarto

Registry-linked trialAbstract read
In one paragraph

Article in British journal of sports medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06518252 (Detection of the Risk of Sudden Cardiac Death in Athletes From the Universidad Nacional de Colombia), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06518252 unknown statusnot on this mapstarted 2023, after this paper: background citation

Detection of the Risk of Sudden Cardiac Death in Athletes From the Universidad Nacional de Colombia

TypeobservationalSponsorUniversidad Nacional de ColombiaRan2023 to 2025Enrolled250ConditionsDeath, Sudden, Cardiac, Electrocardiogram QT Prolonged, Athlete Heart, Athletic Injuries
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Vademecum for the Physician Evaluating a Master Athlete.Current atherosclerosis reports · 2025
    Review
  5. Cardiovascular Pre-participation Evaluation of Athletes with an Impairment Recruited for Paris 2024 Paralympic Games.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025
    Article
  6. Prevalence and relation to training of electrocardiographic findings in Caucasian children and adolescents 8- to 18-year-old practicing competitive sport.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Observational
  7. Article
  8. Pre-participation Cardiovascular Evaluation for Paris 2024 Olympic Games in Elite Athletes: The Italian Experience.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025
    Article
  9. Review
  10. Article
  11. Cardiac Screening in Athletes: Current Status and Future Challenges.Open access journal of sports medicine · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Prevalence and clinical significance of isolated low QRS voltages in young athletes.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Teresina Vessella *Center for Sports Medicine and Exercise Prescription, Treviso, Italy.
Alessandro Zorzi *Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy alessandro.zorzi@unipd.it.ORCID http://orcid.org/0000-0002-3578-0583
Laura MerloCenter for Sports Medicine and Exercise Prescription, Treviso, Italy.
Cinzia PegoraroCenter for Sports Medicine and Exercise Prescription, Treviso, Italy.
Flaviano GiorgianoCenter for Sports Medicine and Exercise Prescription, Treviso, Italy.
Michele TrevisanatoCenter for Sports Medicine and Exercise Prescription, Treviso, Italy.
Mirella VielCenter for Sports Medicine and Exercise Prescription, Treviso, Italy.
Pietro FormentiniCenter for Sports Medicine and Exercise Prescription, Treviso, Italy.
Domenico CorradoDepartment of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
Patrizio SartoCenter for Sports Medicine and Exercise Prescription, Treviso, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionItalian law mandates that every competitive athlete must undergo annual preparticipation evaluation (PPE) to identify cardiovascular (CV) diseases that pose a risk of sudden death (SD) during sport and other conditions that may threaten the athlete's health. We investigated the diagnostic yield, rate of disqualification and costs of our PPE.

methodsWe included 5910 consecutive apparently healthy athletes (61% males, mean age 15±4 years) who underwent annual PPE performed by a sports medicine specialist. The PPE included history, physical examination, weight, height and blood pressure measurement, test of visual acuity, spirometry, urine chemistry, resting 12-lead ECG and exercise testing with ECG monitoring. In cases of abnormal findings, we carried out second-line investigations.

resultsDuring a 12-month study period, 5.326 (90.2%) athletes were cleared for competition after a normal first-line evaluation and 584 (9.8%) underwent one or more further examinations. Of those, 88 (1.5%) were diagnosed to have a CV disease (including 18 (0.3%) at-risk of SD) and 31 (0.5%) had a non-CV diagnosis. A total of 32 (0.5%) athletes were temporarily (n=15) or permanently (n=17) disqualified from competitive sports. The average cost per athlete was €79, which consisted of €64 (80%) for first-line evaluations and €15 (20%) for additional investigations.

conclusionPPE according to the Italian model identified a range of diseases in 2.0% of apparently healthy athletes at an average cost of €79.

Indexed as

Costs and Cost AnalysisAdolescentAdultCardiovascular DiseasesChildDeath, Sudden, CardiacExercise TestFemaleHumansItalyMaleMiddle AgedPhysical ExaminationSpirometrySportsUrinalysisathletescost–benefit analysispreparticipation screeningsports medicinesudden death

Identifiers

PMID31315826
PMCPMC7029244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.